Global Non Hodgkin Lymphoma (NHL) Market Research Report 2022

SKU ID : QYR-21348688 | Publishing Date : 18-Jul-2022 | No. of pages : 84

Request a free Sample

Detailed TOC of Global Non Hodgkin Lymphoma (NHL) Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Non Hodgkin Lymphoma (NHL) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Standard
        1.2.3 Exellent
    1.3 Market by Application
        1.3.1 Global Non Hodgkin Lymphoma (NHL) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hosptial
        1.3.3 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Non Hodgkin Lymphoma (NHL) Market Perspective (2017-2028)
    2.2 Non Hodgkin Lymphoma (NHL) Growth Trends by Region
        2.2.1 Non Hodgkin Lymphoma (NHL) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Non Hodgkin Lymphoma (NHL) Historic Market Size by Region (2017-2022)
        2.2.3 Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Region (2023-2028)
    2.3 Non Hodgkin Lymphoma (NHL) Market Dynamics
        2.3.1 Non Hodgkin Lymphoma (NHL) Industry Trends
        2.3.2 Non Hodgkin Lymphoma (NHL) Market Drivers
        2.3.3 Non Hodgkin Lymphoma (NHL) Market Challenges
        2.3.4 Non Hodgkin Lymphoma (NHL) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Non Hodgkin Lymphoma (NHL) Players by Revenue
        3.1.1 Global Top Non Hodgkin Lymphoma (NHL) Players by Revenue (2017-2022)
        3.1.2 Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Players (2017-2022)
    3.2 Global Non Hodgkin Lymphoma (NHL) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Non Hodgkin Lymphoma (NHL) Revenue
    3.4 Global Non Hodgkin Lymphoma (NHL) Market Concentration Ratio
        3.4.1 Global Non Hodgkin Lymphoma (NHL) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Non Hodgkin Lymphoma (NHL) Revenue in 2021
    3.5 Non Hodgkin Lymphoma (NHL) Key Players Head office and Area Served
    3.6 Key Players Non Hodgkin Lymphoma (NHL) Product Solution and Service
    3.7 Date of Enter into Non Hodgkin Lymphoma (NHL) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Non Hodgkin Lymphoma (NHL) Breakdown Data by Type
    4.1 Global Non Hodgkin Lymphoma (NHL) Historic Market Size by Type (2017-2022)
    4.2 Global Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Type (2023-2028)
5 Non Hodgkin Lymphoma (NHL) Breakdown Data by Application
    5.1 Global Non Hodgkin Lymphoma (NHL) Historic Market Size by Application (2017-2022)
    5.2 Global Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Non Hodgkin Lymphoma (NHL) Market Size (2017-2028)
    6.2 North America Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022)
    6.3 North America Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Non Hodgkin Lymphoma (NHL) Market Size (2017-2028)
    7.2 Europe Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022)
    7.3 Europe Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Non Hodgkin Lymphoma (NHL) Market Size (2017-2028)
    8.2 Asia-Pacific Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Non Hodgkin Lymphoma (NHL) Market Size (2017-2028)
    9.2 Latin America Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022)
    9.3 Latin America Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size (2017-2028)
    10.2 Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 F. Hoffmann-La Roche
        11.1.1 F. Hoffmann-La Roche Company Detail
        11.1.2 F. Hoffmann-La Roche Business Overview
        11.1.3 F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Introduction
        11.1.4 F. Hoffmann-La Roche Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
        11.1.5 F. Hoffmann-La Roche Recent Development
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Detail
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Non Hodgkin Lymphoma (NHL) Introduction
        11.2.4 Johnson & Johnson Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Development
    11.3 Merck
        11.3.1 Merck Company Detail
        11.3.2 Merck Business Overview
        11.3.3 Merck Non Hodgkin Lymphoma (NHL) Introduction
        11.3.4 Merck Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
        11.3.5 Merck Recent Development
    11.4 Bristol Myers Squibb
        11.4.1 Bristol Myers Squibb Company Detail
        11.4.2 Bristol Myers Squibb Business Overview
        11.4.3 Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Introduction
        11.4.4 Bristol Myers Squibb Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
        11.4.5 Bristol Myers Squibb Recent Development
    11.5 Celgene
        11.5.1 Celgene Company Detail
        11.5.2 Celgene Business Overview
        11.5.3 Celgene Non Hodgkin Lymphoma (NHL) Introduction
        11.5.4 Celgene Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
        11.5.5 Celgene Recent Development
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Detail
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Non Hodgkin Lymphoma (NHL) Introduction
        11.6.4 Eli Lilly Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
        11.6.5 Eli Lilly Recent Development
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Company Detail
        11.7.2 GlaxoSmithKline Business Overview
        11.7.3 GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Introduction
        11.7.4 GlaxoSmithKline Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
        11.7.5 GlaxoSmithKline Recent Development
    11.8 Bayer
        11.8.1 Bayer Company Detail
        11.8.2 Bayer Business Overview
        11.8.3 Bayer Non Hodgkin Lymphoma (NHL) Introduction
        11.8.4 Bayer Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
        11.8.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Non Hodgkin Lymphoma (NHL) Market Research Report 2022

List of Tables
    Table 1. Global Non Hodgkin Lymphoma (NHL) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Standard
    Table 3. Key Players of Exellent
    Table 4. Global Non Hodgkin Lymphoma (NHL) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Non Hodgkin Lymphoma (NHL) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Non Hodgkin Lymphoma (NHL) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Non Hodgkin Lymphoma (NHL) Market Share by Region (2017-2022)
    Table 8. Global Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Non Hodgkin Lymphoma (NHL) Market Share by Region (2023-2028)
    Table 10. Non Hodgkin Lymphoma (NHL) Market Trends
    Table 11. Non Hodgkin Lymphoma (NHL) Market Drivers
    Table 12. Non Hodgkin Lymphoma (NHL) Market Challenges
    Table 13. Non Hodgkin Lymphoma (NHL) Market Restraints
    Table 14. Global Non Hodgkin Lymphoma (NHL) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Non Hodgkin Lymphoma (NHL) Market Share by Players (2017-2022)
    Table 16. Global Top Non Hodgkin Lymphoma (NHL) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Hodgkin Lymphoma (NHL) as of 2021)
    Table 17. Ranking of Global Top Non Hodgkin Lymphoma (NHL) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Non Hodgkin Lymphoma (NHL) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Non Hodgkin Lymphoma (NHL) Product Solution and Service
    Table 21. Date of Enter into Non Hodgkin Lymphoma (NHL) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Non Hodgkin Lymphoma (NHL) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Type (2017-2022)
    Table 25. Global Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Type (2023-2028)
    Table 27. Global Non Hodgkin Lymphoma (NHL) Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Application (2017-2022)
    Table 29. Global Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Application (2023-2028)
    Table 31. North America Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. F. Hoffmann-La Roche Company Detail
    Table 42. F. Hoffmann-La Roche Business Overview
    Table 43. F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Product
    Table 44. F. Hoffmann-La Roche Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022) & (US$ Million)
    Table 45. F. Hoffmann-La Roche Recent Development
    Table 46. Johnson & Johnson Company Detail
    Table 47. Johnson & Johnson Business Overview
    Table 48. Johnson & Johnson Non Hodgkin Lymphoma (NHL) Product
    Table 49. Johnson & Johnson Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022) & (US$ Million)
    Table 50. Johnson & Johnson Recent Development
    Table 51. Merck Company Detail
    Table 52. Merck Business Overview
    Table 53. Merck Non Hodgkin Lymphoma (NHL) Product
    Table 54. Merck Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022) & (US$ Million)
    Table 55. Merck Recent Development
    Table 56. Bristol Myers Squibb Company Detail
    Table 57. Bristol Myers Squibb Business Overview
    Table 58. Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Product
    Table 59. Bristol Myers Squibb Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022) & (US$ Million)
    Table 60. Bristol Myers Squibb Recent Development
    Table 61. Celgene Company Detail
    Table 62. Celgene Business Overview
    Table 63. Celgene Non Hodgkin Lymphoma (NHL) Product
    Table 64. Celgene Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022) & (US$ Million)
    Table 65. Celgene Recent Development
    Table 66. Eli Lilly Company Detail
    Table 67. Eli Lilly Business Overview
    Table 68. Eli Lilly Non Hodgkin Lymphoma (NHL) Product
    Table 69. Eli Lilly Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022) & (US$ Million)
    Table 70. Eli Lilly Recent Development
    Table 71. GlaxoSmithKline Company Detail
    Table 72. GlaxoSmithKline Business Overview
    Table 73. GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Product
    Table 74. GlaxoSmithKline Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022) & (US$ Million)
    Table 75. GlaxoSmithKline Recent Development
    Table 76. Bayer Company Detail
    Table 77. Bayer Business Overview
    Table 78. Bayer Non Hodgkin Lymphoma (NHL) Product
    Table 79. Bayer Revenue in Non Hodgkin Lymphoma (NHL) Business (2017-2022) & (US$ Million)
    Table 80. Bayer Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non Hodgkin Lymphoma (NHL) Market Share by Type: 2021 VS 2028
    Figure 2. Standard Features
    Figure 3. Exellent Features
    Figure 4. Global Non Hodgkin Lymphoma (NHL) Market Share by Application in 2021 & 2028
    Figure 5. Hosptial Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Non Hodgkin Lymphoma (NHL) Report Years Considered
    Figure 8. Global Non Hodgkin Lymphoma (NHL) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Non Hodgkin Lymphoma (NHL) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Non Hodgkin Lymphoma (NHL) Market Share by Region: 2021 VS 2028
    Figure 11. Global Non Hodgkin Lymphoma (NHL) Market Share by Players in 2021
    Figure 12. Global Top Non Hodgkin Lymphoma (NHL) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Hodgkin Lymphoma (NHL) as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Non Hodgkin Lymphoma (NHL) Revenue in 2021
    Figure 14. North America Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Non Hodgkin Lymphoma (NHL) Market Share by Country (2017-2028)
    Figure 16. United States Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Non Hodgkin Lymphoma (NHL) Market Share by Country (2017-2028)
    Figure 20. Germany Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market Share by Region (2017-2028)
    Figure 28. China Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Non Hodgkin Lymphoma (NHL) Market Share by Country (2017-2028)
    Figure 36. Mexico Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Non Hodgkin Lymphoma (NHL) Market Share by Country (2017-2028)
    Figure 40. Turkey Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. F. Hoffmann-La Roche Revenue Growth Rate in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
    Figure 43. Johnson & Johnson Revenue Growth Rate in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
    Figure 44. Merck Revenue Growth Rate in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
    Figure 45. Bristol Myers Squibb Revenue Growth Rate in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
    Figure 46. Celgene Revenue Growth Rate in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
    Figure 47. Eli Lilly Revenue Growth Rate in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
    Figure 49. Bayer Revenue Growth Rate in Non Hodgkin Lymphoma (NHL) Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed